Pulse Biosciences (PLSE) Operating Expenses (2015 - 2026)

Pulse Biosciences has reported Operating Expenses for 12 years, with the latest figure at $25.7 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 26.79% year-over-year to $25.7 million in Q2 2026; TTM through Jun 2026 was $85.0 million, a 17.6% increase from a year earlier, with the FY2025 full-year figure at $77.3 million, up 37.39% from the prior year.
• Operating Expenses was $25.7 million for Q2 2026 at Pulse Biosciences, up from $18.5 million in the prior quarter.
• The five-year high for Operating Expenses was $25.7 million in Q2 2026, with the low at $8.7 million in Q4 2022.
• Average Operating Expenses over 5 years is $15.4 million, with a median of $14.3 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses plunged 46.25% in 2022, then jumped 72.91% in 2025.
• Over 5 years, Operating Expenses stood at $8.7 million in 2022, then surged by 43.46% to $12.5 million in 2023, then soared by 61.66% to $20.3 million in 2024, then declined by 8.61% to $18.5 million in 2025, then soared by 38.82% to $25.7 million in 2026.
• The last three Operating Expenses figures came in at $25.7 million (Q2 2026), $18.5 million (Q4 2025), and $20.5 million (Q3 2025), per Business Quant data.